Read the latest and past features

As Autoimmune Awareness Month ends, it is worth remembering that people with autoimmune conditions often face the same challenges: delayed diagnosis, difficult symptoms, and a need for better treatments and more research.

This period of the year can feel like a fresh start, but it can also be a mixed experience if you live with psoriasis or psoriatic arthritis. 

Psoriasis and psoriatic arthritis (PsA) are well known to many of us, but common myths can add to the emotional burden, shape how others respond, and delay recognition and treatment. Read some of the myths people still face.

Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, are often recommended as first-line treatments to ease pain, stiffness, and joint inflammation in mild psoriatic arthritis (PsA).

March is Autoimmune Awareness Month. This year, PAPAA is joining our Connect Immune Research partners to highlight the impact of autoimmune conditions and the importance of working together to improve understanding, treatment and support.

PAPAA is marking Rare Disease Day today, 28 February, by shining a light on the lesser-known but serious forms of psoriatic disease that affect people and families worldwide.

In our recent feature, Dry January: A simple reset for people with psoriatic disease, we explored how taking a break from alcohol can ease pressure on your liver, support your medicines and reduce a known trigger for some people.

Young adults aged 18-35 living with psoriasis or psoriatic arthritis: your voice can transform global awareness.

The International Federation of Psoriasis Associations (IFPA) and the WHO Foundation have signed a multi-year agreement to bolster WHO's efforts in enhancing global understanding, diagnosis, and care for psoriasis.

Research shows that people with psoriasis and psoriatic arthritis can have a higher risk of heart disease and stroke because of ongoing inflammation and other related health factors.